There are several innovations in the treatment of benign prostatic hyperplasia (BPH), all focusing on minimally invasive procedures with faster recovery times and fewer side effects than traditional surgery. Here are a few examples:

Minimally invasive surgical therapies (MIST): These procedures use various technologies to open up the blocked urethra in the prostate. Some of the latest MIST techniques include:

• Aquablation: This procedure uses a robotic device to deliver high-pressure jets of sterile water to remove prostate tissue blocking the urethra.
• Rezūm: This uses radiofrequency energy delivered through a transurethral needle to create small zones of tissue death within the prostate, which gradually shrinks the enlarged tissue.
• UroLift: This minimally invasive procedure involves tiny implants placed underneath the prostate to hold the prostate lobes apart, opening the urethra.
• Drug-coated balloons: A new development is the Optilume BPH Catheter System, which uses a balloon to open the urethra and deliver a paclitaxel drug to prevent the prostate tissue from closing up again.

These are just a few examples, and new technologies are constantly being developed. It's important to talk to your doctor about the best treatment option for you.

Reference

https://doi.org/10.1016/j.prnil.2023.01.002, i.a.